Spots Global Cancer Trial Database for Group-based or Individual Information About Disease and Treatment Plan
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Group-based or Individual Information About Disease and Treatment Plan
Official Title: Cancer Patients' Knowledge and Satisfaction After Group-based or Individual Information About Their Disease and Treatment Plan
Study ID: NCT01699672
Interventions
Study Description
Brief Summary: The main aim of the current study is to investigate whether the addition of a standardized,group-based educational program to the information provided by health care personnel improves cancer patients' knowledge level about their disease, planned treatment and common side-effects of the treatment. Secondary aims are to investigate if the addition of the educational program increases the likelihood of completing treatment as planned, reduces level of anxiety, reduces the frequency of serious side effects, increases patient reported health related quality of life, and increases the degree of patient satisfaction with respect to how they have received the information before, during and after treatment.
Detailed Description: There are strong indications that group-based information provides better information for cancer patients about their disease, treatment options - and potential benefits and side effects of the planned therapy than information provided during a regular doctor consultation. The investigators believe that standardizing and repeating the information as well as having more time for questions in an open environment for reflections will improve the amount of information patients can perceive. Furthermore, all patients will be given written information. Better-informed patients may be more motivated and may contact health care personnel earlier than other patients when they develop side effects. This may reduce the risk of serious treatment-related complications and increase the chances of patients completing the planned treatment. But none have compared to what extent an organization like Vardesenteret improves the patients' knowledge and whether patients are more satisfied with these methods for informing them. Results from studies on the influence of patient anxiety and distress on patient's abilities to perceive information are conflicting.Two large groups of relatively homogenous cancer patients are patients with lower-stage breast cancer patients who are eligible for adjuvant chemotherapy and patients with localized prostate cancer eligible for curative radiotherapy.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
St Olavs Hospital, Trondheim, , Norway
Contact Details
Name: Stein Kaasa, MD, Prof.
Affiliation: St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center
Role: PRINCIPAL_INVESTIGATOR
Name: Ola Berger, MD
Affiliation: St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center
Role: STUDY_DIRECTOR
Name: Bjørn H Gønberg, MD, PhD
Affiliation: St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center
Role: STUDY_CHAIR
Name: Kari Sand, Cand Philol
Affiliation: PRC, European Palliative Care Research Center
Role: STUDY_CHAIR
Name: Jo Å Lund, MD, PhD
Affiliation: St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center
Role: STUDY_CHAIR
Name: Jon H Loge, MD, Prof.
Affiliation: National Resource Centre for Studies of Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Department of Behavioral Sciences in Medicine, University of Oslo
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
